ANDREW ZIMOLZAK to Drug Monitoring
This is a "connection" page, showing publications ANDREW ZIMOLZAK has written about Drug Monitoring.
Connection Strength
0.461
-
Early detection of poor adherers to statins: applying individualized surveillance to pay for performance. PLoS One. 2013; 8(11):e79611.
Score: 0.328
-
Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial. JAMA Netw Open. 2020 12 01; 3(12):e2027092.
Score: 0.134